Health Care & Life Sciences

WellPoint unit, hospital group hit impasse on contract

October 2, 2014
Associated Press
Contract talks broke down Wednesday between Anthem Blue Cross and Blue Shield and a network of five hospitals and other facilities, leaving tens of thousands of patients facing higher health insurance costs.
More

Lilly to end development of lupus drug after trial failure

October 2, 2014
Associated Press
Tabalumab was expected to generate about $250 million to $300 million a year in sales in several years.
More

U.S. judge blocks Obamacare tax rule for non-exchange states

September 30, 2014
Bloomberg News
An Oklahoma federal judge dealt a blow to President Barack Obama’s health-care law, invalidating IRS rules aimed at making policies affordable for consumers around the country.
More

Endocyte faces big decisions with new cancer drug

September 29, 2014
J.K. Wall
Endocyte's lead drug showed big impact on lung cancer patients, but some analysts think the company should scrap it for a newer drug that is more powerful.
More

The Interview Issue: Ron Ellis

September 27, 2014
J.K. Wall
Ron Ellis has been CEO of the drug discovery firm Endocyte Inc. since 1996. When he moved to West Lafayette to take the job, he wouldn’t let his wife paint the interior of their new house—for fear he’d be looking for a new job soon. Endocyte has yet to generate any revenue.
More

IU Health CFO: 3 years to go in difficult transition

September 26, 2014
J.K. Wall
Kitchell Watch videoIn the past two years, IU Health has laid off 935 people, halted construction of a major bed tower, sold off health clinics and decided to close its proton-therapy center. But there are three more years of changes to come, said CFO Ryan Kitchell.
More

Experts: Telemedicine can bridge mental health gap

September 25, 2014
Associated Press
Modern technology offers a way to deliver much-needed mental health care to rural sections of Indiana where little or none is available, experts told a legislative study committee Thursday.
More

Advocates seek action on Indiana Medicaid plan

September 25, 2014
Associated Press
Health care advocates and industry lobbyists are asking federal officials for speedy approval of Indiana's request for a Medicaid expansion.
More

Rise in bed sores pushes state medical errors to new high

September 25, 2014
 Associated Press and IBJ Staff
Overall, 111 medical errors were reported in 2013, the biggest number in any year since the state began reporting them in 2006.
More

Major Health to put new $89 million hospital along I-74

September 24, 2014
J.K. Wall
Major Health Partners will construct the new hospital on the north edge of Shelbyville, after nearly a decade of shifting services to that location. Construction could begin next month.
More

LDI acquisition could be latest springboard for growth

September 23, 2014
Jeff Newman
Indianapolis-based private investment company LDI Ltd. has acquired a small biotech manufacturer in a deal it says could be the launching point for many more acquisitions.
More

IU Health to bypass Indy next year on Obamacare exchange

September 22, 2014
J.K. Wall
IU Health Plans, the insurance arm of the Indianapolis-based hospital system, is limiting itself to three middle-size markets next year—Bloomington, Lafayette and Muncie—even though the bulk of its facilities is in the metro area.
More

FDA approves Eli Lilly's injectable diabetes drug

September 18, 2014
Associated Press
The agency on Thursday cleared the drug, Trulicity, as a weekly injection to improve blood sugar control in patients with type 2 diabetes, which affects more than 26 million Americans.
More

Obamacare enrollment at 7.3 million people, official says

September 18, 2014
Bloomberg News
That’s a 9-percent reduction from the government’s May estimate of 8 million, which reflected only how many people had signed up, not how many had paid and were enrolled in the coverage.
More

Testosterone drugs need study on heart risks, FDA panel says

September 18, 2014
Bloomberg News
Drugmakers, including Eli Lilly and Co., should conduct new trials to assess the heart risks of testosterone therapies used by millions of men last year, advisers to U.S. regulators said.
More

Abortion-related complaints filed against doctors

September 17, 2014
Associated Press
Attorney General Greg Zoeller's office filed licensing complaints Wednesday against an Illinois doctor facing misdemeanor charges in Indiana and against three physicians who perform abortions in Indianapolis.
More

Community Health plans $175M expansion of East facilities

September 17, 2014
J.K. Wall
Community executives said the investment and projects, which will begin this fall and extend over several years, prove their long-term commitment to the east side of the city.
More

FDA set to review testosterone-boosting drug usage

September 16, 2014
Bloomberg News
Testosterone supplements used last year by about 2.3 million men are spurring debates over how necessary and safe they may be, even as U.S. regulators consider approving a new product.
More

Lilly to pay AstraZeneca up to $500M in Alzheimer’s push

September 16, 2014
Bloomberg News
The two companies will work together to develop AZD3293, which belongs to a novel class of drugs called BACE inhibitors that block production of amyloid, a protein that causes plaque to build up in the brain of Alzheimer’s patients.
More

Sheriffs: Mentally ill people swamping Indiana jails

September 15, 2014
Associated Press
County jails have become the "insane asylum" for Indiana as state hospital care for the mentally ill has declined, a sheriff told a legislative committee in Indianapolis on Monday.
More

Recent wins worth $4B to Lilly market value

September 15, 2014
J.K. Wall
Lilly is finally putting meat on the bones of its predictions about its experimental diabetes and cancer drugs. That gives investors the certainty they crave that Lilly’s future revenue won’t remain in its 2014 doldrums.
More

Lilly cancer drug fares well in late-stage study

September 12, 2014
Associated Press
Eli Lilly and Co. said Friday its potential colorectal cancer drug Cyramza helped patients on chemotherapy with advanced cases of the disease survive longer than patients on chemotherapy alone.
More

Lilly receives European marketing OK for new insulin

September 10, 2014
Associated Press
European regulators have approved a long-lasting insulin from Eli Lilly and Co. and German drugmaker Boehringer Ingelheim that is the subject of patent-infringement litigation with French rival Sanofi.
More

Feds OKs $1.8 million for health exchange helpers

September 9, 2014
Associated Press
The U.S. Department of Health and Human Services is sending Indiana money to help the state's health care plan navigators sign up more residents through a federally run exchange.
More

Startup Companion Diagnostics trying to work through bankruptcy

September 8, 2014
J.K. Wall
Companion Diagnostics Inc., a biotech company that relocated to Indiana from Connecticut in 2010, has entered bankruptcy reorganization while it tries to develop a therapy for inflammation.
More
Page  1 2 3 4 5 6 7 8 9 10 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
thisissue1-092914.jpg 092914

Subscribe to IBJ
  1. Cramer agrees...says don't buy it and sell it if you own it! Their "pay to play" cost is this issue. As long as they charge customers, they never will attain the critical mass needed to be a successful on company...Jim Cramer quote.

  2. My responses to some of the comments would include the following: 1. Our offer which included the forgiveness of debt (this is an immediate forgiveness and is not "spread over many years")represents debt that due to a reduction of interest rates in the economy arguably represents consideration together with the cash component of our offer that exceeds the $2.1 million apparently offered by another party. 2. The previous $2.1 million cash offer that was turned down by the CRC would have netted the CRC substantially less than $2.1 million. As a result even in hindsight the CRC was wise in turning down that offer. 3. With regard to "concerned Carmelite's" discussion of the previous financing Pedcor gave up $16.5 million in City debt in addition to the conveyance of the garage (appraised at $13 million)in exchange for the $22.5 million cash and debt obligations. The local media never discussed the $16.5 million in debt that we gave up which would show that we gave $29.5 million in value for the $23.5 million. 4.Pedcor would have been much happier if Brian was still operating his Deli and only made this offer as we believe that we can redevelop the building into something that will be better for the City and City Center where both Pedcor the citizens of Carmel have a large investment. Bruce Cordingley, President, Pedcor

  3. I've been looking for news on Corner Bakery, too, but there doesn't seem to be any info out there. I prefer them over Panera and Paradise so can't wait to see where they'll be!

  4. WGN actually is two channels: 1. WGN Chicago, seen only in Chicago (and parts of Canada) - this station is one of the flagship CW affiliates. 2. WGN America - a nationwide cable channel that doesn't carry any CW programming, and doesn't have local affiliates. (In addition, as WGN is owned by Tribune, just like WTTV, WTTK, and WXIN, I can't imagine they would do anything to help WISH.) In Indianapolis, CW programming is already seen on WTTV 4 and WTTK 29, and when CBS takes over those stations' main channels, the CW will move to a sub channel, such as 4.2 or 4.3 and 29.2 or 29.3. TBS is only a cable channel these days and does not affiliate with local stations. WISH could move the MyNetwork affiliation from WNDY 23 to WISH 8, but I am beginning to think they may prefer to put together their own lineup of syndicated programming instead. While much of it would be "reruns" from broadcast or cable, that's pretty much what the MyNetwork does these days anyway. So since WISH has the choice, they may want to customize their lineup by choosing programs that they feel will garner better ratings in this market.

  5. The Pedcor debt is from the CRC paying ~$23M for the Pedcor's parking garage at City Center that is apprased at $13M. Why did we pay over the top money for a private businesses parking? What did we get out of it? Pedcor got free parking for their apartment and business tenants. Pedcor now gets another building for free that taxpayers have ~$3M tied up in. This is NOT a win win for taxpayers. It is just a win for Pedcor who contributes heavily to the Friends of Jim Brainard. The campaign reports are on the Hamilton County website. http://www2.hamiltoncounty.in.gov/publicdocs/Campaign%20Finance%20Images/defaultfiles.asp?ARG1=Campaign Finance Images&ARG2=/Brainard, Jim

ADVERTISEMENT